Evidence map›Paper›PMID 34245143›Full record

ArticleBriefings in bioinformatics2021

Performance evaluation of transcriptomics data normalization for survival risk prediction.

Ai Ni, Li-Xuan Qin

Open access · hybridAbstract read
In one paragraph

Article in Briefings in bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Deep learning in bioinformatics.Turkish journal of biology = Turk biyoloji dergisi · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ai NiOhio State University, New York, NY 10017 USA.ORCID 0000-0003-3002-3556
Li-Xuan QinMemorial Sloan Kettering Cancer Center, New York, NY 10017 USA.
Memorial Sloan Kettering Cancer Center · USState University of New York · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Evaluation and Development of Statistical Methods for Data Harmonization in Molecular PrognosticationR21HG012124 · NHGRI · SLOAN-KETTERING INST CAN RESEARCH · PI QIN, LI-XUAN · 2021 to 2021
$496k
Statistical Evaluation and Selection of Normalization Methods for microRNA Sequencing Data in Cancer Biomarker StudiesR21CA214845 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI QIN, LI-XUAN · 2018 to 2019
$414k
NCI NIH HHS P30 CA008748NCI NIH HHS R21 CA214845NHGRI NIH HHS R21 HG012124NIH HHS CA214845
6 · The paper itself

Abstract

One pivotal feature of transcriptomics data is the unwanted variations caused by disparate experimental handling, known as handling effects. Various data normalization methods were developed to alleviate the adverse impact of handling effects in the setting of differential expression analysis. However, little research has been done to evaluate their performance in the setting of survival outcome prediction, an important analysis goal for transcriptomics data in biomedical research. Leveraging a unique pair of datasets for the same set of tumor samples-one with handling effects and the other without, we developed a benchmarking tool for conducting such an evaluation in microRNA microarrays. We applied this tool to evaluate the performance of three popular normalization methods-quantile normalization, median normalization and variance stabilizing normalization-in survival prediction using various approaches for model building and designs for sample assignment. We showed that handling effects can have a strong impact on survival prediction and that quantile normalization, a most popular method in current practice, tends to underperform median normalization and variance stabilizing normalization. We demonstrated with a small example the reason for quantile normalization's poor performance in this setting. Our finding highlights the importance of putting normalization evaluation in the context of the downstream analysis setting and the potential of improving the development of survival predictors by applying median normalization. We make available our benchmarking tool for performing such evaluation on additional normalization methods in connection with prediction modeling approaches.

Indexed as

BiomarkersTranscriptomeAlgorithmsComputational BiologyGene Expression ProfilingGene Expression RegulationMicroRNAsMortalityPrognosisProportional Hazards ModelsBiomarkersMicroRNAsdata normalizationhandling effectsmicroRNA microarraypenalized Cox regressionsurvival predictiontranscriptomics data

Identifiers

PMID34245143
PMCPMC8575026
OpenAlexW3179200440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.